EVLO — Evelo Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Evelo Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	148	77.8	68.9	68.4	47.9
Prepaid Expenses
Total Current Assets	152	81	71	71	51.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.92	8.34	18.2	15.5	11.7
Other Long Term Assets
Total Assets	160	90.9	90.6	87.9	64.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.23	9.74	19.8	17.4	12.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.9	30.7	60.2	79.2	69.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	137	60.2	30.5	8.67	-4.99
Total Liabilities & Shareholders' Equity	160	90.9	90.6	87.9	64.4
Total Common Shares Outstanding